Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
Open | $0.64 |
Close | $0.62 |
Volume / Avg. | 225.32K / 163.19K |
Day Range | $0.62 - $0.64 |
52 Wk Range | 0.61 - 1.56 |
Market Cap | $23.53M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 0.74% |
Days to Cover | 2.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Geovax Labs (NASDAQ:GOVX), Palatin Techs (AMEX:PTN), Cue Biopharma (NASDAQ:CUE) and Lisata Therapeutics (NASDAQ:LSTA).
There is no analysis for Bolt Biotherapeutics to provide a consensus price target.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.615 last updated September 20, 2024 at 4:05 PM EDT.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.